Infeksi Hepatitis B Tersamar (Occult Hepatitis B Infection) dan Kanker Hati Primer
DOI:
https://doi.org/10.29303/jku.v5i3.303Keywords:
Hepatitis B tersamar, kanker hati primerAbstract
Infeksi virus hepatitis B tersamar merupakan infeksi yang masih menjadi masalah karena prevalensinya yang cukup tinggi dan berpengaruh pada keselamatan terutama dalam praktik donor darah. Virus Hepatitis B merupakan virus yang paling sering ditransmisikan melalui transfusi dan terdapat kemungkinan transmisi berasal dari virus hepatitis B tersamar. Padahal, telah diketahui bahwa terdapat hubungan yang erat antara infeksi hepatitis B tersamar dan kejadian sirosis dan kanker hati primer.
References
1. Allain J. Occult Hepatitis B Virus Infection (Review Article). Hepatitis B Annual. 2005;2:14–30.
2. Van Hemert F, Zaaijer H, Berkhout B, Lukashov V. Occult Hepatitis B Infection : An Evolutionary Scenario. Virology Journal. 2008;5:146.
3. Zahn A, Li C, Danso K, Candotti D, Ofori O, Temple J, et al. Molecular Characterization of Occult Hepatitis B Virus in Genotype E-Infected Subjects. Journal of General Virology. 2008;89:409–418.
4. Reesink H, Engelfriet C, Henn G, Mayr W, Delage G, Benier F, et al. Occult Hepatitis B Infection in Blood Donors. Vox Sanguinis. 2008;94:153–166.
5. Kaminski G, Alnagdy A, Belushi I, Nograles J, Dhahry S. Evidence of Occult Hepatitis B Virus Infection among Omani Blood Donors: A Preliminary Study. Med Princ Pract. 2006;15:368– 372.
6. Soewignjo S, Gunawan S. Hepatitis Virus B. EGC Jakarta. 1999;.
7. Cacciola I, Pollicino T, Sguardrito G, Cerenzia G, Orlando M, Raimondo G. Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease. The New Englan Journal of Medicine. 1999;341:22–26.
8. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, et al. Occult Hepatitis B Virus Infection in HBs Antigen-Negative Heptocellulear Carcinoma in A Japanese Population: Involvement of HBx and p53. J Med Virol. 2000;62:151–158.
9. Siregar F. Hepatitis B Ditinjau dari Kesehatan Masyarakat dan Upaya Pencegahan. Kumpulan Artikel Kesehatan Masyarakat Fakultas Kesehatan Masyarakat USU. 2004;.
10. Marrero J, Lok A. Occult Hepatitis B Virus Infection in Patients with Hepatocellular Carcinoma: Innocent Bystander, Cofactor, or Culprit? Gastroenterology. 2004;126:347–350.
11. Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, et al. Previous or Occult Hepatitis B Virus Infection in Hepatitis B Surface Antingen-Negative
and Anti-Heptitis C-Negative Patients with Hepatocellular Carcinoma. Surgery Today. 2004;34:842–848.
12. Goncales F, Pereira S, Silva C, Thomaz G, Pavan M, Fais V, et al. Hepatitis B Virus DNA in Sera of Blood Donors and of Patients Infected with Hepatitis C Virus and Human Immunodeficiency Virus. Clinical and Diagnostic Laboratory Immunology. 2003;10:718–720.
13. Persico E, Renzo A, Mura V, Bruno S, Masarone M, Torella R, et al. Occult Hepatitis B Virus Infection in Patients with Non-Hodgkin Lymphoma: The Need for Early Diagnosis in Anti- HBc Positive Patients. Gut. 2007;56:1470–1471.
14. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, et al. Italian Blood Donors with Anti-HBc and Occult Hepatitis B Virus Infection. Haematologica. 2007;92:1664–1670.
15. Laguna M, Larrousse M, Blanco J, Leon A, Milinkovic A, Robezler M, et al. Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV-HCV-Coinfected Patients. Aids Research and Human Restoviruses. 2008;24:547–553.
2. Van Hemert F, Zaaijer H, Berkhout B, Lukashov V. Occult Hepatitis B Infection : An Evolutionary Scenario. Virology Journal. 2008;5:146.
3. Zahn A, Li C, Danso K, Candotti D, Ofori O, Temple J, et al. Molecular Characterization of Occult Hepatitis B Virus in Genotype E-Infected Subjects. Journal of General Virology. 2008;89:409–418.
4. Reesink H, Engelfriet C, Henn G, Mayr W, Delage G, Benier F, et al. Occult Hepatitis B Infection in Blood Donors. Vox Sanguinis. 2008;94:153–166.
5. Kaminski G, Alnagdy A, Belushi I, Nograles J, Dhahry S. Evidence of Occult Hepatitis B Virus Infection among Omani Blood Donors: A Preliminary Study. Med Princ Pract. 2006;15:368– 372.
6. Soewignjo S, Gunawan S. Hepatitis Virus B. EGC Jakarta. 1999;.
7. Cacciola I, Pollicino T, Sguardrito G, Cerenzia G, Orlando M, Raimondo G. Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease. The New Englan Journal of Medicine. 1999;341:22–26.
8. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, et al. Occult Hepatitis B Virus Infection in HBs Antigen-Negative Heptocellulear Carcinoma in A Japanese Population: Involvement of HBx and p53. J Med Virol. 2000;62:151–158.
9. Siregar F. Hepatitis B Ditinjau dari Kesehatan Masyarakat dan Upaya Pencegahan. Kumpulan Artikel Kesehatan Masyarakat Fakultas Kesehatan Masyarakat USU. 2004;.
10. Marrero J, Lok A. Occult Hepatitis B Virus Infection in Patients with Hepatocellular Carcinoma: Innocent Bystander, Cofactor, or Culprit? Gastroenterology. 2004;126:347–350.
11. Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, et al. Previous or Occult Hepatitis B Virus Infection in Hepatitis B Surface Antingen-Negative
and Anti-Heptitis C-Negative Patients with Hepatocellular Carcinoma. Surgery Today. 2004;34:842–848.
12. Goncales F, Pereira S, Silva C, Thomaz G, Pavan M, Fais V, et al. Hepatitis B Virus DNA in Sera of Blood Donors and of Patients Infected with Hepatitis C Virus and Human Immunodeficiency Virus. Clinical and Diagnostic Laboratory Immunology. 2003;10:718–720.
13. Persico E, Renzo A, Mura V, Bruno S, Masarone M, Torella R, et al. Occult Hepatitis B Virus Infection in Patients with Non-Hodgkin Lymphoma: The Need for Early Diagnosis in Anti- HBc Positive Patients. Gut. 2007;56:1470–1471.
14. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, et al. Italian Blood Donors with Anti-HBc and Occult Hepatitis B Virus Infection. Haematologica. 2007;92:1664–1670.
15. Laguna M, Larrousse M, Blanco J, Leon A, Milinkovic A, Robezler M, et al. Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV-HCV-Coinfected Patients. Aids Research and Human Restoviruses. 2008;24:547–553.
Downloads
Published
2016-09-28
How to Cite
Triani, E. (2016). Infeksi Hepatitis B Tersamar (Occult Hepatitis B Infection) dan Kanker Hati Primer. Jurnal Kedokteran, 5(3), 45. https://doi.org/10.29303/jku.v5i3.303
Issue
Section
Literature Review
